retatrutide ly3437943 triple agonist glp-1 gip glucagon Eli Lilly just announced striking Phase 3 results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Efficacy and safety of retatrutide,

Antioxidant Properties Glutathione is an antioxidant that helps lighten the skin in major ways

NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease

Shen, C

Indole-3-carbinol forms diindolylmethane in the stomach, activates the aryl hydrocarbon receptor, shifts estrogen metabolism toward 2-hydroxylation, and induces cytochrome P450 1A1

Shared pathomechanisms of neuropsychiatric syndromes with fatigue as a leading symptom (PASC, PAIS, ME/CFS, IMD) Alterations of brain structure and connectivity PASC is currently being investigated by neuroimaging experts all over the world